Primary Site >> Pancreatic Cancer
Gene >> ALK
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Modulation of enzymatic activities during spontaneous and induced differentiation in a human pancreatic adenocarcinoma cell line CAPAN-1. PMID: 2543714 |
Ref: Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. PMID: 9850059 |
Ref: Primary anaplastic large cell lymphoma of the small intestine. PMID: 10549257 |
Ref: Primary ALK positive anaplastic large cell lymphoma of the pancreas. PMID: 12691166 |
Ref: Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer. PMID: 22973962 Ref: Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors. PMID: 23673444 Ref: Rare ALK expression but no ALK rearrangement in pancreatic ductal adenocarcinoma and neuroendocrine tumors. PMID: 23851431 Ref: Occurrence of anaplastic large cell lymphoma following IgG4-related autoimmune pancreatitis and cholecystitis and diffuse large B-cell lymphoma. PMID: 24228121 |
Ref: MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside. PMID: 23992325 Ref: Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer. PMID: 25193856 Ref: Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: rationale and progress. PMID: 25382190 |
Ref: Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment. PMID: 27041411 |